Rabies. Issues for Travel. Kevin C. Kain MD Professor of Medicine, University of Toronto Director, Center for Travel and Tropical Medicine
|
|
- Jerome Hodge
- 5 years ago
- Views:
Transcription
1 Rabies Issues for Travel Kevin C. Kain MD Professor of Medicine, University of Toronto Director, Center for Travel and Tropical Medicine
2 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical, including photocopying, recording, or information storage and retrieval systems without prior written permission of Sea Courses Inc. except where permitted by law. Sea Courses is not responsible for any speaker or participant s statements, materials, acts or omissions.
3 BLUF: Bottom Line Up Front Everyone who travels internationally on expeditions should be offered/receive a 3 dose preexposure series of a modern cell based rabies vaccine Be aware of bites and other exposures and implement immediate first aid
4 Objectives Advise: Should most adventure/international travelers should consider (get!) pre-exposure vaccination? Update: Post bite management With and w/o pre-exposure prophylaxis Inform: Product specific issues HRIG Worldwide availability of vaccines
5 Rabies Acute viral encephalomyelitis Transmission Animal to animal Animal to human Dramatic symptoms Colorful history 100% fatal infection
6 Rabies: Historical Perspective Louis Pasteur July 1885, Pasteur inoculated Joseph Meister, a 9 yr old boy bitten 14 times by a rabid dog, 13 times over 10 days Vaccine was a suspension of dried rabbit spinal cord
7 Lyssaviruses Genotype Virus Name Geographic Distribution 1 Rabies bats in Americas; terrestrial mammals globally Description Classic rabies Protection with RAB vaccine Yes 2 Lagos bat Sub-Saharan Africa Fruit Bats; never in humans 3 Mokola Sub-Saharan Africa Shrew; lethal infection in rabies vaccinated dogs; cats; 2 human deaths 4 Duvenhage Sub-Saharan Africa Rabies like illness / deaths in humans; bats no no Yes 5 European bat lyssavirus type 1 Europe Bats; human case in Russia Yes 6 European bat lyssavirus type 2 Europe Bats, human case in Finland Yes 7 Australian bat lyssavirus Australia bats Yes
8 The Rabies Virus Family Rhabdoviridae Genus Lyssavirus Enveloped viruses Single negative strand RNA Bullet shaped 5 structural proteins G glycoprotein elicits virus-neutralizing antibodies or VNA
9 Neurologic Clinics : Rabies Pathogenesis Days to weeks to reach CNS from bite site Virus attaches to nicotininc acetylcholine receptors at neuromuscular junction Travels mm per day in rodents Encephalitis is widespread but neuronal destruction is not Once in CNS, virus travels back down axon of peripheral nerves, esp. to salivary glands
10 Rabies: Clinical Disease Incubation period days (range, 5 days - 7 years) < 1% cases with incubation period > 6 months Shorter when bite is on head / face / fingers Non-specific prodrome (2-10 days) Fever, malaise, headache, anxiety, agitation Pain and paresthesias at bite site
11 Rabies: Clinical Disease Acute neurological phase (2-12 days) Furious rabies in 60-80% Hydrophobia, aerophobia, hyperexcitability, autonomic dysfunction Paralytic rabies in 20% - 33% Progressive paresthesias and flaccid paralysis Coma (hours to months) Death is cardiorespiratory
12 Rabies: Diagnosis Clinical Suspicion Hx of exposure (travel, bite, bat contact) Pain / paresthesia at bite site, hydrophobia, hypersalivation, aerophobia Identification of virus in nerve tissue Ag (FAT), specific inclusions (Negri bodies), RNA, virus isolation (cornea, neck hairline), RT-PCR Serology RFFIT
13 Rabies virus Negri body Electron micrograph of rabies virus in brain cells at 64,000 x magnification. Courtesy of Dr. F.A. Murphy, UC Davis.
14 Diagnosis: detection of rabies antigen The fluorescent antibody test (FAT) is considered the gold standard for rabies diagnosis. Specific aggregates of rabies virus antigen are detected by their fluorescence. The FAT is accurate, sensitive and rapid. Results can often be obtained within 1 to 2 hours of receipt of the specimen.
15 How do you get rabies? Exposure to saliva bites or licks/scratches to mm and broken skin Improperly inactivated vaccine Solid organ transplantation Cornea Aerosols Occupational (lab) Caves (bats) Human to human (all body fluids!) Intercourse, kissing, lactation, skin contamination, bites
16 Travel and Rabies Rabies in travelers is rare Bites / rabies exposures are common Many rabies cases in developed countries acquired while traveling Bites and exposures are not rare 13 dog bites per 1000 in Thailand Post exposure dilemmas and travelers are common
17
18 Bites and Exposures 10% of travellers report a dog bite or lick during an average of 17 days of travel Ann Med Interne (Paris) 145:409, bites in short term travel (85% < 3 months) Dogs in 51%, monkeys in 21%, cats in 8% Vaccine Mar 30;25(14):
19 GeoSentinel Data 320 episodes of animal-related injuries were reported to GeoSentinel during the period of January 1998 May 2005, representing 1.4% of the 23,509 ill returned travellers entered into the database during this period. 54.7% female compared to 47.4% male Females more likely to be injured by monkeys Males were more likely to be injured by dogs. Only 66.1% of all patients reported with animalrelated injury received rabies post-exposure prophylaxis
20 Who is higher risk? Rural travel Cycling dogs hate cyclists! Areas populated with stray dogs Children 4X higher risk More likely to be bitten Less likely to report it More facial and upper extremity bites Boys > girls Spelunkers and other cave activities
21 Bite Management Pre-exposure Rabies vaccine 3 doses: 0, 7, 28 No pre-exposure Rabies Vaccine Dog bite! Wound Care! Post-exposure Management: 2 doses of vaccine 3 days apart Post-exposure Management: 1) 4 doses of vaccine 0,3,7,14 2) HRIG
22 Prevention Don t get bitten Presume all dogs have rabies Don t contact or handle bats Don t feed or annoy monkeys (don t carry food in temples) Pre-travel vaccine X 3 Wound care Get cell based vaccine X 2 if bitten
23 N=10,499 travellers and 4854 expats 2533 environmental illnesses 3.3% of travellers and 1.8% of ex-pats received a bite requiring rabies prophylaxis (#1 = dogs; #2 = monkeys)
24
25 Post-exposure Management Vaccine plus passive antibodies (rabies immune globulin) Must give both Fatal human cases documented in those receiving vaccine only JAMA 1982:248; Lancet 1982:2;870.
26 The Importance of HRIG Exposure: Injection into Masseter muscle of dogs HDCV only HRIG only Combination HRIG + HDCV 0% 20% 50% Exposure: Injection into Femoral muscle of dogs HDCV only HRIG only Combination HRIG + HDCV 0% 50% 100% Can J Vet Res 53: , 1989
27 Rabies Immune Globulin (RIG) Derived from horses: Equine rabies immune globulin (ERIG) Derived from humans: Human rabies immune globulin (HRIG)
28 ERIG: Equine Rabies Immune Globulin Multiple products worldwide - India, SE Asia None approved in USA or other Western countries Anaphylaxis Serum sickness Contaminating equine viruses Skin test pre-administration? Intermittent availability Generally lower cost
29 HRIG: Human Rabies Immune Globulin Two products in NA: HyperRab (Talecris BIotherapeutics) Imogam Rabies - HT (Aventis Pasteur) Not reliably available overseas Expensive Both products 150 IU / ml 2 ml vials = 300 IU = 15 kg person 10 ml vials = 1500 IU = 75 kg person Require cold chain storage (2-8º C) No preservatives Do not freeze
30 HRIG: Human Rabies Immune Globulin Passive transfer of antibodies to rabies virus Intervention yields low level antibodies lasting for days Give 20 IU / kg on Day 0 Full dose given at bite site if anatomically feasible At least half of volume injected at bite site Other half injected IM in gluteal or thigh area (different site than vaccine which is deltoid) Works best when given shortly after bite Not indicated more than 7 days after post-exposure immunization begins May interfere with immune response to vaccine if given > 7 days after vaccine
31 HRIG / perig Local infiltration is very important Total dose if possible 5 children in Thailand died when local infiltration of perig not performed Clin Infect Dis 22: , 1996
32 Why should you get pretravel rabies vaccine? If bitten, you don t need HRIG Non-bite exposures Child tropism to animals / dogs Kids face at mouth level of dogs Kids may not report minor bites to caregiver/parents Pre-travel rabies immunization is a form of trip insurance.
33 Rabies: What Vaccines to Use Approved mammalian cell culture vaccines (CCVs) Human Diploid cell vaccine (HDCV) Purified Vero Cell Vaccine (PVRV) Purified chick embryo vaccine (PCEC) Purified duck embryo vaccine (PDEV) Avoid neurotissue vaccines Derived directly from sheep or mouse brain
34 Rabies Vaccine Timeline Pasteur - inactivated by drying Semple - phenol inactivated Fuenzalida - myelin free Crude neuro-tissue preparations HDCV licensed by FDA Increasing Purity Number of Doses
35 FDA Approved Rabies Vaccines Imovax (Aventis-Pasteur, France) FDA approved 1980 HDCV Rabavert (Chiron Behring Gmbh & Co) Manufactured in Marburg, Germany FDA approved in 1997
36 Efficacy of Pre-Exposure Vaccine No cases of rabies ever documented in a person who received three 1.0 ml doses IM and appropriate postexposure management.
37 Immunogenicity of Imovax Post-exposure prophylaxis 45 persons bitten by rabid wolves and dogs in Iran (JAMA :2751-4) All rec d vaccine and anti-rabies globulin Hours to days after exposure All protected
38 Administration of HDCVs Vaccine failure when given in gluteal area presumably due to sub Q fat Give only in deltoid muscle for adults and children Mid-lateral thigh in infants and very small children NEJM : MMWR :
39 Immunogenicity of CCVs 1 Corticosteroids and other immunosuppressive drugs can interfere with the development of rabies antibodies following vaccination. Post anesthesia has been associated with a decrease in protective efficacy
40 Immunogenicity of CCVs 2 Anti-malarial chemoprophylaxis with chloroquine (? mefloquine?) can decrease antibody response to HDCV NEJM 314:280, 1986 Complete pre-exposure rabies vaccine series before beginning malaria prophylaxis with CQ or MQ
41 Hypersensitivity Reactions to HDCV? Modern CCVs not associated with systemic reactions following boosters Additional purification steps to remove human albumin HDCVs Pasteur Mérieux Connaught Canada, Berna, and Behring PVRV and PCECV PMC and Chiron
42 Pre-Exposure Vaccine Schedules: Decreasing Cost in LDCs USA CDC / ACIP FDA approved vaccines ACIP guidelines Three 1.0 ml doses given IM pre-travel: D0, D7, D21-28 No FDA approved or ACIP recommended ID ROA regimen $500-$1000 per three dose series Worldwide WHO Many CCVs WHO guidelines Three 1.0 ml doses given IM pre-travel: D0, D7, D21-28 Three 0.1 ml doses given ID pre-travel: D0, D7, D21-28 Much lower cost = greater use / access
43 Post-Exposure Vaccine Schedules: Decreasing Cost in LDCs USA CDC / ACIP FDA approved vaccines ACIP guidelines Four 1.0 ml doses given IM pre-travel: D0, D3, D7, D14 No FDA approved or ACIP recommended ID regimen All suspect exposures receive vaccine and HRIG Worldwide WHO Many CCVs WHO guidelines The indication for postexposure prophylaxis depends on the type of contact with the suspected rabid animal Much lower cost = greater use / access
44
45 WHO Post-Exposure Prophylaxis ID Administration
46 Overseas, remote area, you get bitten Clean water, soap, povidone, etc. Who do you see? Where do you go? How do you assess products? Can you trust the products? Can you find RIG? Can you pay for it? You are scared, really Your trip is over
47 When traveling and you need rabies vaccine, how do you know what to use? Caveat Emptor! Poorly made / manufactured Proper vaccines, improperly stored Proper vaccines, improperly stored Counterfeit vaccines Can t locate CCVs
48 Caveat Emptor! Substandard Manufacture Illegal Counterfeit / Fakes
49 Treatment Failures: Rabies Despite Modern Vaccines 28 Cases reviewed 25 / 28 (90%) failed to use HRIG or used HRIG incorrectly No HRIG Poor or no wound cleaning Very late start of HRIG Injection of vaccine into buttocks instead of deltoid Late use of immunization 2 cases of severe facial injury considered true Rx failure Thraenhart O et al. Curr Top Microbiol Immunol 1994: 187;
50 Post-Exposure Management: PCECV w/o HRIG? 15 million doses with 47 failures 100% of failures did not follow accepted WHO guidelines for HRIG International Rabies Meeting; Institute Pasteur, Paris; 1997
51 Rationale for Pre-Exposure Prophylaxis for Travelers Up side / Benefit Protection from inapparent exposures Protection if post-exposure prophylaxis likely to be delayed Eliminates need for ERIG/HRIG Decreases the number of doses for postexposure (2 vs. 5) Avoids possibility of receiving neurotissue vaccines Avoids possibility of receiving fake / counterfeit vaccines Children at higher risk = greater benefit for pre-exposure Very safe / low reactogenicity risk of modern CCVs Prevent 100% fatal disease Greatly simplifies post-exposure management Cost Down side / Risk
52 Case CRYPTIC CASES (i.e. No history of exposure) are the #1 cause of rabies deaths in the USA! Genetically BAT origin
53 Bats and rabies USA MMWR April 13, cases of rabies % travel related dogs 71% of USA cases bats
54 Bats host major viruses Drexler et al. Nature April 27, 2012;766 Bats are the origin of paramyxoviruses mumps, measles, RSV, paraflu Hendra and Nipah fatal encephalitis in Australia/Asia African origin rinderpest, distemper PLUS 67 new ones! Live in large colonies with viral genetic mixing and transmission. Implications: disease emergence & elimination
55
56
57 Monkeys and Rabies Can monkeys get rabies? YES Yes most will give rabies vaccine/rig Only 5 reported human cases from monkeys - Gautret et al. PloS ND May 2014 Why so rare? TOO Fast and TOO smart! (unlike humans!)
58 Rodents and Rabies KTM reports 30 rat bites/day! Can mice/rats get rabies YES In USA no reported human cases Elsewhere rare but reported e.g. Thailand n=7000 cases 1% Poland n= % Why so rare? usually killed in the initial attack
RABIES. Zeliha Koçak Tufan, MD, Assoc. Prof. Yildirim Beyazit University Infectious Diseases & Clinical Microbiology Department
RABIES Zeliha Koçak Tufan, MD, Assoc. Prof. Yildirim Beyazit University Infectious Diseases & Clinical Microbiology Department Please focus on the pathogenesis and prophylaxis plus wound care!! What is
More informationGENUS LYSSAVIRUS IT IS ALMOST A 100% FATAL DISEASE OF HUMANS AND OTHER ANIMALS.
GENUS LYSSAVIRUS RABIES VIRUS IT IS ALMOST A 100% FATAL DISEASE OF HUMANS AND OTHER ANIMALS. IT HAS BEEN KNOWN SINCE THE 23 CENTURY B.C. RABIES IS PRESENT IS THE SALIVA OF RABID ANIMALS AND IS TRANSMITTED
More informationOREGON PUBLIC HEALTH DIVISION IMMUNIZATION PROTOCOL FOR PHARMACISTS RABIES INACTIVATED VIRUS VACCINE FOR PRE-EXPOSURE PROPHYLAXIS ONLY
OREGON PUBLIC HEALTH DIVISION IMMUNIZATION PROTOCOL FOR PHARMACISTS RABIES INACTIVATED VIRUS VACCINE FOR PRE-EXPOSURE PROPHYLAXIS ONLY Review 06-2010 No changes to the PRE-EXPOSURE protocol of 2008. See
More informationPage 1 of 11 Medical Summary RABIES GENERAL INFORMATION Introduction Rabies is an acute, progressive infection of the central nervous system caused by neurotropic viruses in the family Rhabdoviridae, genus
More informationGUIDELINES FOR MANAGEMENT OF SUSPECTED RABIES EXPOSURES January, 2010
Ministry of Health and Long-Term Care Ministère de la Santé et des Soins de longue durée GUIDELINES FOR MANAGEMENT OF SUSPECTED RABIES EXPOSURES January, 2010 All suspected incidents must be reported to
More informationNEW JERSEY DEPARTMENT OF HEALTH & SENIOR SERVICES
NEW JERSEY DEPARTMENT OF HEALTH & SENIOR SERVICES NEW JERSEY GUIDE TO POST-EXPOSURE RABIES PROPHYLAXIS FOR THE HEALTH CARE PROFESSIONAL July 2011 BACKGROUND Raccoon rabies entered New Jersey in the fall
More informationRABIES Pr P ese e n se t n er e : J. J. K a K m a bo b n o a n a (M.B. B Ch C. h B; B M.Med e ) d
RABIES Presenter: J.J. Kambona (M.B.Ch.B; M.Med) OBJECTIVES At the end of this session each student will be able to: 1. Define rabies. 2. Describe the epidemiology of rabies. 3. Describe the cause of rabies.
More informationNEW YORK STATE DEPARTMENT OF HEALTH Updated February 1, 1999 Rabies Policies and Procedures (518) (518) (after hours)
NEW YORK STATE DEPARTMENT OF HEALTH Updated February 1, 1999 Rabies Policies and Procedures (518) 474-3186 (518) 465-9720 (after hours) SUBJECT: Guidance Regarding Human Rabies Exposure and Treatment Decisions
More informationRabies. By Alexa Smith. Rabies Virus (Rabies); Etiological agent Family Rhabdoviridae. Genus- lyssavirus (1). Transmission:
Rabies By Alexa Smith Rabies Virus (Rabies); Etiological agent Family Rhabdoviridae. Genus- lyssavirus (1). Transmission: The virus can enter a host via a parenteral route. The saliva of the infected host
More informationThis is risky. Rabies. Are you at risk?
This is risky. Rabies Are you at risk? Are you at risk of rabies? You are at risk if you are in contact with potentially rabid animals: t Laboratory workers, veterinarians t Animal control workers, animal
More informationProtocol for Rabies Post-exposure Prophylaxis (RPEP) After Exposure to a Rabies Susceptible Animal 1,2
Protocol for Rabies Post-exposure Prophylaxis (RPEP) After Exposure to a Rabies Susceptible Animal 1,2 Post-exposure Rabies Vaccine Schedule Update The March 19, 2010 issue of the Centers for Disease Control
More informationRabies Epidemiology K require rabies post-exposure prophylaxis annually. Medical urgency, not medical emergency $300 million annually
Rabies Rabies Epidemiology 16-39K require rabies post-exposure prophylaxis annually Medical urgency, not medical emergency $300 million annually About 1 or 2 cases of rabies annually in US Sources of Exposure
More informationPolicy Statement Rabies-Prevention Policy Update: New Reduced-Dose Schedule
FROM THE AMERICAN ACADEMY OF PEDIATRICS Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of all Children Policy Statement Rabies-Prevention Policy Update:
More informationRabies Prevention and Post- Deployment Assessments: Information for Providersand Public Health Personnel
U.S. Army Public Health Command Public Health Notice Rabies Prevention and Post- Deployment Assessments: Information for Providersand Public Health Personnel December 2012 U.S. Army Public Health Command
More informationRABIES PROTECTION PROGRAM
Page 1 of 5 STANDARD OPERATING PROCEDURES (SOP) SCOPE Rabies is a virus causing an acute central nervous system infection, which is typically transmitted by introducing the rabies virus into open cuts
More informationCanadian Immunization Guide
Home > Immunization & Vaccines > Canadian Immunization Guide > Rabies Vaccine Canadian Immunization Guide T [Previous page] [Table of Contents] [Next page] Part 4 Active Vaccines Rabies Vaccine Epidemiology
More informationRepublic of the Philippines. Department of Health OFFICE OF THE SECRETARY. June 8, 2009 ADMINISTRATIVE ORDER. No:
Republic of the Philippines Department of Health OFFICE OF THE SECRETARY June 8, 2009 ADMINISTRATIVE ORDER No: 2009-0027 1 / 22 SUBJECT: Amendment to AO 2007-0029 regarding the Revised Guidelines on. I.
More informationRabies. By Rosa Reynoso. Rabies; Etiological Agent: Rhabdoviridae family Lyssavirus genus type (4)
Rabies By Rosa Reynoso Rabies; Etiological Agent: Rhabdoviridae family Lyssavirus genus type (4) Transmision: It is a zoonotic disease transmitted from infected animals to humans (4). Infected animals
More informationPresented by. Professor Dr. Md. Zakir Hossain. Professor & Head Department of Medicine Rangpur Medical College & Hospital
Rabies Presented by Professor Dr. Md. Zakir Hossain MBBS, FCPS, MD(Internal Medicine), FACP Professor & Head Department of Medicine Rangpur Medical College & Hospital Rangpur Medical College Rangpur Medical
More informationLONG-TERM PROTECTIVE RABIES ANTIBODIES IN THAI CHILDREN AFTER PRE-EXPOSURE RABIES VACCINATION
LONG-TERM PROTECTIVE RABIES ANTIBODIES IN THAI CHILDREN AFTER PRE-EXPOSURE RABIES VACCINATION Supawat Chatchen, Shakil Ibrahim, Pataporn Wisetsing and Kriengsak Limkittikul Department of Tropical Pediatrics,
More informationFACTORS AFFECTING COMPLIANCE TO RABIES POST-EXPOSURE PROPHYLAXIS AMONG PEDIATRIC PATIENTS SEEN AT THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE
56 ORIGINAL ARTICLE FACTORS AFFECTING COMPLIANCE TO RABIES POST-EXPOSURE PROPHYLAXIS AMONG PEDIATRIC PATIENTS SEEN AT THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE AUTHORS: Ruth Faye Romero-Sengson *Philippine
More informationCNS MODULE. Dr Hamed Al-Zoubi Ass. Prof. of Microbiology
CNS MODULE Dr Hamed Al-Zoubi Ass. Prof. of Microbiology Enteroviruses Picornaviridae family 1. Enteroviruses a) Polioviruses types 1, 2 and 3 b) Coxsackieviruses A1-A24 (no A23), B1-B6 c) Echoviruses 1
More informationRabies Postexposure Prophylaxis in a UK Travel Clinic: Ten Years Experience
Rabies Postexposure Prophylaxis in a UK Travel Clinic: Ten Years Experience 257 Limin Wijaya, MRCP (UK), Lisa Ford, MBBS, and David Lalloo, FRCP Department of Infectious Disease, Singapore General Hospital,
More informationAnimal Bites and Rabies. Patty W. Wright, M.D. 2018
Animal Bites and Rabies Patty W. Wright, M.D. 2018 Objectives To inform participants about the treatment of common animal bites To discuss the indications for and administration of pre- and post-exposure
More informationBelow you will find information about diseases, the risk of contagion, and preventive vaccinations.
Vaccinations Below you will find information about diseases, the risk of contagion, and preventive vaccinations. DTP - Diphtheria Tetanus Polio Yellow fever Hepatitis A Typhoid fever Cerebrospinal meningitis
More informationTwelve Common Questions About Human Rabies and Its Prevention
Published in Infectious Diseases in Clinical Practice (2000) 9:202-207 Twelve Common Questions About Human Rabies and Its Prevention Robert V. Gibbons, MD, MPH Charles Rupprecht, DVM Viral and Rickettsial
More informationRabies. Prevention in travellers. Clinical features. clinical. Background. Objective. Discussion
clinical Rabies Amy A Neilson Cora A Mayer Prevention in travellers This article forms part of our travel medicine series for 2010, providing a summary of prevention strategies and vaccination for infections
More informationEconomical intradermal rabies vaccine application By F.X Meslin and M.Warrell at the occasion of the international seminar on "intradermal
Economical intradermal rabies vaccine application By F.X Meslin and M.Warrell at the occasion of the international seminar on "intradermal immunization: an alternative route for vaccine administration"
More informationGuidance Document for the Management of Suspected Rabies Exposures
Guidance Document for the Management of Suspected Rabies Exposures This document is in support of the Rabies Prevention and Control Protocol, 2008 (or as current) under the Ontario Public Health Standards.
More informationUpdates in rabies vaccine protocols and diagnostic techniques used globally and nationally
Updates in rabies vaccine protocols and diagnostic techniques used globally and nationally Susan Moore, Rabies Laboratory/KSVDL/College of Veterinary Medicine/Kansas State University, Manhattan, KS 66502,
More informationAcute neurological syndromes
Acute neurological syndromes Assoc.Prof. Murat Sayan Kocaeli Üniversitesi, Rutin PCR Lab. Sorumlu Öğt.Üyesi Yakın Doğu Üniversitesi, DESAM Kurucu Öğrt. Üyesi sayanmurat@hotmail.com 0533 6479020 Medical
More informationThe Immunological Basis for Immunization Series
The Immunological Basis for Immunization Series Module 17: Rabies Immunization, Vaccines and Biologicals The Immunological Basis for Immunization Series Module 17: Rabies Immunization, Vaccines and Biologicals
More informationClinical Pharmacology
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 RabAvert Rabies Vaccine Rabies Vaccine for Human Use Description RabAvert, Rabies Vaccine, produced by Novartis Vaccines and Diagnostics
More informationOn track for 2020? Towards the WHO roadmap's targets for neglected tropical diseases
MEEREB, 08 April 2015 Fondation Merieux, Lyon France On track for 2020? Towards the WHO roadmap's targets for neglected tropical diseases Dr Bernadette Abela-Ridder Department of Control of Neglected Tropical
More informationPoliovirus replication
Poliovirus Poliovirus It belongs to the Enteroviruses genus of the picornavirus family which replicate mainly in the gut. Single stranded naked RNA virus with icosahedral symmetry Capsid has 60 copies
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the product: 1.1 Product name: EQUIRAB Rabies Antiserum - Equine 1.2 Strength: 1000 I.U. / 5 ml 1.3 Pharmaceutical Dosage form: Injection 2. Qualitative and
More informationRabAvert Rabies Vaccine
PRESCRIBING INFORMATION RabAvert Rabies Vaccine Rabies Vaccine for Human Use DESCRIPTION RabAvert Rabies Vaccine produced by GlaxoSmithKline GmbH is a sterile, freeze-dried vaccine obtained by growing
More informationManagement of Potential Rabies Exposures Guideline, 2018
Ministry of Health and Long-Term Care Management of Potential Rabies Exposures Guideline, 2018 Population and Public Health Division, Ministry of Health and Long-Term Care Effective: January 1, 2018 or
More informationIMOGAM RABIES PASTEURIZED - HUMAN RABIES IMMUNOGLOBULIN. Active ingredient: Human proteins mg
IMOGAM RABIES PASTEURIZED - HUMAN RABIES IMMUNOGLOBULIN COMPOSITION 1 ml of human rabies immunoglobulin contains: Active ingredient: Human proteins 100 180 mg containing (IgG class) human rabies immunoglobulins
More informationRabies Vaccine IMOVAX RABIES
046 90408-0 Rabies Vaccine IMOVAX RABIES WISTAR RABIES VIRUS STRAIN PM-1503-3M GROWN IN HUMAN DIPLOID CELL CULTURES Page 1 of 8 DESCRIPTION The Imovax Rabies Vaccine produced by Aventis Pasteur is a sterile,
More informationRABIES IMMUNOGLOBULIN. Kanishka Singh Choudhary* and Gunjan Jadon Shrinathji Institute of Pharmacy, Nathdwara. (Raj.)
Available online on www.ijarpb.com Review Article Received on 17/12/2013; Revised on 20/12/2014; Accepted 28/12/2013; Abstract RABIES IMMUNOGLOBULIN Kanishka Singh Choudhary* and Gunjan Jadon Shrinathji
More informationCE Unit. Viruses and Vaccines
CE Unit Viruses and Vaccines DO NOT WRITE What is a virus? Have you ever had a virus? What is a vaccine? How is a virus different from bacteria? What are the deadliest viruses? 10. Dengue fever 50 million
More informationPRODUCT MONOGRAPH. RabAvert. Rabies Vaccine. Freeze-dried vaccine for reconstitution with a diluent 2.5 IU of rabies antigen
PRODUCT MONOGRAPH RabAvert Rabies Vaccine Freeze-dried vaccine for reconstitution with a diluent 2.5 IU of rabies antigen Therapeutic Classification: Active Immunising Agent GlaxoSmithKline Inc. 7333 Mississauga
More informationIMMUNOGENICITY AND FEASIBILITY OF PURIFIED CHICK EMBRYO CELL VACCINE
IMMUNOGENICITY AND FEASIBILITY OF PURIFIED CHICK EMBRYO CELL VACCINE S. Sehgal M. Bhardwaj D. Bhattacharya ABSTRACT Two hundred seventy-one children reported at the WHO Collaborative Centre for Rabies
More informationThe Global Availability of Rabies Immune Globulin and Rabies Vaccine in Clinics Providing Direct Care to Travelers
1 ORIGINAL ARTICLE The Global Availability of Rabies Immune Globulin and Rabies Vaccine in Clinics Providing Direct Care to Travelers Emily S. Jentes, PhD, Jesse D. Blanton, MPH, Katherine J. Johnson,
More informationCost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children
Vaccine 24 (2006) 1478 1482 Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children Pannipa Chulasugandha a,, Pakamatz Khawplod a, Piyalamporn Havanond b, Henry
More informationEvidence to Recommendation Table 1
Evidence to Recommendation Table 1 Questions: Can the duration of the entire course and/or the number of doses administered of current PEP regimens be reduced while maintaining immunogenicity and effectiveness?
More informationRabies. By: Christopher Solomon. Disease: Rabies etiologic agent: Lyssavirus (1)
Rabies By: Christopher Solomon Disease: Rabies etiologic agent: Lyssavirus (1) Transmission: Transmission of this disease is most often transmitted by the bite of an infected or rabid animal (2). Reservoirs:
More informationRabies immunoprophylaxis strategy in travelers
Journal of Wilderness Medicine 2, 15-21 (1991) ORIGINAL ARTICLE Rabies immunoprophylaxis strategy in travelers D.R. SHLIM*, E. SCHWARTZ and R. HOUSTON CIWEC Clinic, POB 1340, Kathmandu, Nepal We present
More informationRabies. By Sarah C. Rivera
Rabies By Sarah C. Rivera Etiologic Agent: As a current veterinary technician, rabies is a word spoken all too often and without thinking twice. The clinic where I work is an approved rabies quarantine
More informationThe African lyssaviruses
Animal rabies: BATS Primary reservoirs for all except Mokola Wide diversity of species, large numbers, widespread, often protected Human rabies bat origin only in Americas Rupprecht Lancet Infect Dis 2002
More informationPUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA
INFLUENZA DEFINITION Influenza is an acute highly infectious viral disease characterized by fever, general and respiratory tract catarrhal manifestations. Influenza has 3 Types Seasonal Influenza Avian
More informationIntroduction. Infections acquired by travellers
Introduction The number of Australians who travel overseas has increased steadily over recent years and now between 3.5 and 4.5 million exits are made annually. Although many of these trips are to countries
More informationConsiderations for Tetanus While Treating an Exposure to Rabies
Considerations for Tetanus While Treating an Exposure to Rabies Since rabies and tetanus are not as common in the United States (US) as they used to be, 1,2 people may not be fully aware of these diseases
More informationBackground paper: PROPOSED REVISION OF THE POLICY ON RABIES VACCINES AND RABIES IMMUNOGLOBULINS
Background paper: PROPOSED REVISION OF THE POLICY ON RABIES VACCINES AND RABIES IMMUNOGLOBULINS Prepared by the SAGE Working Group on Rabies vaccines and immunoglobulins and the World Health Organization
More informationPRODUCT MONOGRAPH. RabAvert. Rabies Vaccine. Freeze-dried vaccine for reconstitution with a diluent 2.5 IU of rabies antigen
PRODUCT MONOGRAPH RabAvert Rabies Vaccine Freeze-dried vaccine for reconstitution with a diluent 2.5 IU of rabies antigen Therapeutic Classification: Active Immunising Agent GlaxoSmithKline Inc. 7333 Mississauga
More informationPhilippe Lagacé Wiens M.D., DTM&H, FRCPC
Philippe Lagacé Wiens M.D., DTM&H, FRCPC ay yah FYAH lah yer kuhl 1. Describe the pathogenesis (steps in causing disease) of the rabies virus starting from the bite of an infected animal death of the
More informationUpdate. Wilderness Medicine Update W-1. Anaphylaxis. Malaria. Rabies. Robert C. Allen, DO, FACEP. Acute Mountain Sickness (AMS)
XX-12 GRABLEfired on May 25, 1953 at the NevadaTest Site.A 280mm artillery gun fired the 15kilotonnuclearshell. Thiswas theonlytimea nuclearartilleryshellwaseverfired. GroundZerowas 7milesfromthegun. So,
More informationHepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003
Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology
More informationRabies Response. Briefing for the Defense Health Board
Rabies Response Briefing for the Defense Health Board Steven B. Cersovsky, MD, MPH LTC(P), MC, USA Director, Epidemiology & Disease Surveillance 14 November 2011 UNCLASSIFIED Briefing Outline PURPOSE:
More information1.0 GOAL DEFINITIONS RISK ASSESSMENT...
Chapter I - Management of Specific Diseases Table of Contents 1.0 GOAL... 2 2.0 DEFINITIONS... 2 3.0 RISK ASSESSMENT... 3 3.1 EXPOSURE HISTORY... 4 3.1.1 Bats... 5 3.1.2 Terrestrial Mammals... 6 3.1.3
More informationBirth 6 wk 10 wk 14 wk 18 wk 6 mo 9 mo 12 mo 15 mo 18 mo mo 2-3 Yr 4-6 Yr 7-10Yr Yr 13-18Yr
Vaccine BCG Age Birth 6 wk 10 wk 14 wk 18 wk 6 mo 9 mo 12 mo 15 mo 18 mo 19-23 mo 2-3 Yr 4-6 Yr 7-10Yr 11-12 Yr 13-18Yr BCG Hep B Hep B1 Hep B2 Hep B3 Polio OPV 0 IPV1 IPV2 IPV3 OPV1 OPV2 IPV B1 OPV3 DTP
More informationTen Travel Medicine Tips
Ten Travel Medicine Tips (New or important things) Joan Ingram ADHB and DML 1. Risks of various health problems during travel Risks vary with destination GeoSentinel Surveillance Network : 30 travel or
More informationESCMID Online Lecture Library. by author
Challenges and Controversies in Vaccination TRAVEL VACCINES Resat Ozaras, MD, Professor, Istanbul University Cerrahpasa Medical School Infectious Dis. Dept. Risk of exposure The severity of the disease
More informationTHE ASSIST ANT SECRETARY OF DEFENSE
THE ASSIST ANT SECRETARY OF DEFENSE 1200 DEFENSE PENTAGON WASHINGTON, DC 20301-1200 HEALTH AFFAIRS Nov 14, 2011 MEMORANDUM FOR ASSISTANT SECRETARY OF THE ARMY (MANPOWER AND RESERVE AFFAIRS) ASSISTANT SECRETARY
More informationJoe McCormack LYSSAVIRUSES. University of Queensland Mater Hospitals South Brisbane
Joe McCormack LYSSAVIRUSES University of Queensland Mater Hospitals South Brisbane Causes of acute encephalitis Herpes simplex virus type 1 (type 2 in neonates) Arboviruses: : Murray Valley and Kunjin
More informationKEDRAB Rabies Immune Globulin (Human) Solution for intramuscular injection Initial U.S. Approval: 2017
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEDRAB safely and effectively. See full prescribing information for KEDRAB. KEDRAB Rabies Immune
More informationRecommendations on pre-exposure rabies vaccine schedules
Recommendations on pre-exposure rabies vaccine schedules 25 Jan 2018 PATRICK SOENTJENS Chief Medical Physician Travel Clinic ITM, Antwerp Med LtCol Leading Physician ID4C/Travel Clinic Mil Hospital, Brussels
More informationDISEASE. Recommended Childhood Immunization Schedule, Minnesota, 1998
MINNESOTA DEPAR ARTMENT OF HEALTH DISEASE CONTR ONTROL OL NEW EWSLETTER Volume 26, Number 4 (pages 29-36) May/June 1998 Recommended Childhood Immunization Schedule, Minnesota, 1998 The 1998 Recommended
More informationMeasles Update. March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief
Measles Update March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief Colorado Department of Public Health and Environment Presenters have
More informationSCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE NATIONAL CONSENSUS MEETING 2018
SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE WETENSCHAPPELIJKE STUDIEGROEP REISGENEESKUNDE/GROUPE D'ETUDE SCIENTIFIQUE DE LA MEDECINE DES VOYAGES NATIONAL CONSENSUS MEETING 2018 Neder-over-Heembeek, October
More informationApplication Form/Pre-examination Form for IMOVAX POLIO Subcutaneous Injection For optional vaccination
Application Form/Pre-examination Form for IMOVAX POLIO Subcutaneous Injection For optional vaccination Created in February 2016 SPJP.IPV.16.02.0025 To physicians who administer IMOVAX POLIO Subcutaneous
More informationRABIPUR Product Information AUST R Page 1 of 14
Page 1 of 14 DESCRIPTION RABIPUR Inactivated Rabies Virus Vaccine RABIPUR is an inactivated rabies virus vaccine, derived from the fixed-virus strain, Flury LEP. The virus is propagated in a Purified Chick
More informationContinuing Dilemma in Endemic Infection: Rabies in Focus Nancy N. Bermal, MD Fellow: PPS, PIDSP
Continuing Dilemma in Endemic Infection: Rabies in Focus Nancy N. Bermal, MD Fellow: PPS, PIDSP Conflict of Interest Disclosure Currently an employee of GSK Phils Objective To provide update to rabies
More informationFor the use only of registered medical practitioners or a hospital or a laboratory
This package insert is continually updated: please read carefully before using a new pack! For the use only of registered medical practitioners or a hospital or a laboratory Package leaflet Rabipur PCEC
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Read all of this leaflet carefully before you receive this vaccine. - Keep this leaflet. You may need to read it again. - If you have further questions, please ask your doctor
More informationDISCLOSURES. I have no actual or potential conflicts of interest in this presentation.
OVERVIEW ON MEASLES Oneka B. Marriott, DO, MPH, FAAP, FACOP Assistant Professor of Pediatrics and Public Health Nova Southeastern University College of Osteopathic Medicine Presentation to FSACOFP Annual
More informationCE Unit 7. Viruses and Vaccines
CE Unit 7 Viruses and Vaccines DO NOT WRITE What is a virus? Have you ever had a virus? What is a vaccine? How is a virus different from bacteria? What are the deadliest viruses? 10. Dengue fever 50 million
More informationJapanese Encephalitis: Prevention Through Vaccination. Jaime A. Santos
Japanese Encephalitis: Prevention Through Vaccination Jaime A. Santos Outline Introduction: Epidemiology, Disease and Sequelae Prevention: Role of Vaccination Vaccines against JE; SP Chimeric Vaccine Conclusions
More informationby Jean Lang, a Emmanuel Feroldi, a and Nguyen Cong Vien b a Sanofi Pasteur, Marcy L etoile, France
Pre-exposure Purified Vero Cell Rabies Vaccine and Concomitant Routine Childhood Vaccinations: 5-year Post-vaccination Follow-up Study of an Infant Cohort in Vietnam by Jean Lang, a Emmanuel Feroldi, a
More informationWorld Health Organization Communicable Disease Surveillance and Control
WHO/CDS/CSR/APH/2000.5 Intradermal application of rabies vaccines Report of a WHO consultation Bangkok, Thailand 5-6 June 2000 World Health Organization Communicable Disease Surveillance and Control This
More informationMosquitoborne Viral Diseases
Mosquitoborne Viral Diseases Originally prepared by Tom J. Sidwa, D.V.M, M.P.H State Public Health Veterinarian Zoonosis Control Branch Manager Texas Department of State Health Services 1 AGENT Viruses
More informationProduced by Agriculture and Extension Communications, Virginia Tech
revised 2005 publication 420-036 Rabies: Its Ecology, Control, and Treatment Kari Signor, former student, Department of Fisheries and Wildlife Sciences, Virginia Tech James Parkhurst, associate professor,
More informationRhabdoviruses. Rabies is a viral disease that produces an almost uniformly fatal. Virology. Epidemiology
163 Rhabdoviruses SARICE L. BASSIN CHARLES E. RUPPRECHT THOMAS P. BLECK Rabies is a viral disease that produces an almost uniformly fatal encephalitis in humans and most other mammals. It has been present
More informationViral Vaccines I 5/17/04 LECTURE OUTLINE I. CASE HISTORY
Viral Vaccines I I. CASE HISTORY LECTURE OUTLINE 5/17/04 A 22-year-old Amish woman became ill with a headache, fever, and generalized muscle pain. Two days later, she developed right and then left lower
More informationIMOGAM Rabies Pasteurized
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION IMOGAM Rabies Pasteurized Rabies Immune Globulin, Pasteurized (Human) Solution for Injection (150 IU/mL) 2.0 ml vials and 10.0 ml vials Passive
More informationSUMMARY OF PRODUCT CHARACTRISTICS
1. NAME OF THE MEDICINAL PRODUCT Purified, Inactivated, Lyophilized Rabies Vaccine, Prepared on Vero Cells INDIRAB 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative Formula per dose of 0.5 ml (Single
More informationUpdate on Mumps and Current Status of Outbreak in NW Arkansas
Update on Mumps and Current Status of Outbreak in NW Arkansas Dirk Haselow, MD, PhD State Epidemiologist Medical Director for Outbreak Response Arkansas Department of Health 1 Vaccines have been proven
More information6/29/2018 #FSHP2018 #FSHP2018 #FSHP2018 #FSHP2018 #FSHP2018
Disclosure Statement New Drugs I have no conflicts of interest to disclose Steven Walden, PharmD, MPH WellCare Health Plans Manager, Clinical Implementations Learning Objectives At the completion of this
More informationMalaria parasites Malaria parasites are micro-organisms that belong to the genus Plasmodium. There are more than 100 species of Plasmodium, which can infect many animal species such as reptiles, birds,
More informationKnowledge, Attitudes, and Practices of French Travelers from Marseille Regarding Rabies Risk and Prevention
107 Knowledge, Attitudes, and Practices of French Travelers from Marseille Regarding Rabies Risk and Prevention Matthias Altmann, PharmD, MPH, Philippe Parola, MD, PhD, Jean Delmont, MD, Philippe Brouqui,
More information1.0 GOAL DEFINITIONS RISK ASSESSMENT...
Chapter I - Management of Specific Diseases Table of Contents 1.0 GOAL... 2 2.0 DEFINITIONS... 2 3.0 RISK ASSESSMENT... 3 3.1 EXPOSURE HISTORY... 4 3.1.1 Bats... 6 3.1.2 Terrestrial Mammals... 7 3.1.3
More informationHepatitis A is a small, unenveloped, symmetrical RNA virus within the genus Hepatovirus, a member of the Picornavirus family.
Hepatitis A Introduction Hepatitis A is a small, unenveloped, symmetrical RNA virus within the genus Hepatovirus, a member of the Picornavirus family. Epidemiology (Data from the Travel Health Surveillance
More informationThe immunogenicity and safety of vaccination with purified vero cell rabies vaccine (PVRV) in China under a regimen
Research paper Human Vaccines 7:2, 1-5; February 2011; 2011 Landes Bioscience research paper The immunogenicity and safety of vaccination with purified vero cell rabies vaccine (PVRV) in China under a
More informationExpanded Programme on Immunization (EPI):
Expanded Programme on Immunization (EPI): Introduction Four to five million annual deaths could be prevented by 2015 through sustained and appropriate immunization efforts, backed by financial support.
More informationImportant rabies references (mainly )
Important rabies references (mainly 2007-2002) Zinsstag J, Schelling E, Roth F, Bonfoh B, de Savigny D, Tanner M. Human benefits of animal interventions for zoonosis control. Emerg Infect Dis. 2007 Apr;13(4):527-31.
More informationPublic Health Image Library. CDC/ Cynthia Goldsmith. Image #
Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,
More informationRabies Experts Highlight Barriers to Innovation in Rabies Education and Treatment. The Wistar Institute, Philadelphia, PA
YOUR SOURCE FOR RABIES AWARENESS AND EDUCATION Rabies Experts Highlight Barriers to Innovation in Rabies Education and Treatment Broader awareness, increased vigilance, and innovative thinking are more
More informationOREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS INACTIVATED JAPANESE ENCEPHALITIS VIRUS VACCINE
OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS INACTIVATED JAPANESE ENCEPHALITIS VIRUS VACCINE Update as of 06 2010 Addition of IXIARO, Inactivated, Adsorbed vaccine; grown in tissue culture
More informationRABIES IN CHILDREN WHEN TO CONSIDER RABIES AND WHEN TO VACCINATE. Anja Poulsen MD PhD 2017
RABIES IN CHILDREN WHEN TO CONSIDER RABIES AND WHEN TO VACCINATE Anja Poulsen MD PhD 2017 WILL YOU VACCINATE AGAINST RABIES? Mum, dad, children: 9 years old and 12 years old. a. 3 weeks travel to Vietnam,
More information